Response by Mendes-Ferreira et al to Letter Regarding Article, “Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension”

ORIGINAL ARTICLE Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats

August 2016

Abstract: Calorie restriction (CR) is one of the most effective nonpharmacological interventions pro...

Pluripotent stem cell model of pulmonary arterial hypertension

Qian, Ling

January 2017

Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.

Bogaard, Harm J
Legchenko, Ekaterina
Chaudhary, Ketul R
Sun, Xiao-Qing
Stewart, Duncan J
Hansmann, Georg

December 2019

Translational research is essential to develop strategies for the treatment of pulmonary ...

Response by Mendes-Ferreira et al to Letter Regarding Article, “Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension”

Mendes-Ferreira, Pedro
Manaud, Grégoire
Perros, Frédéric

August 2019

Comment onBmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hype...

Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension

Hautefort, Aurélie
Mendes-Ferreira, Pedro
Sabourin, Jessica
Manaud, Grégoire
Bertero, Thomas
Rucker-Martin, Catherine
Riou, Marianne
Adão, Rui
Manoury, Boris
Lambert, Mélanie
Boet, Angele
Lecerf, Florence
Domergue, Valérie
Brás-Silva, Carmen
Gómez, Ana Maria
Montani, David
Girerd, Barbara
Humbert, Marc
Antigny, Fabrice
Perros, Frédéric

February 2019

International audienceBACKGROUND: Monoallelic mutations in the gene encoding bone morphogenetic prot...

Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension

Tu, Ly
Desroches-Castan, Agnes
Mallet, Christine
Guyon, Laurent
Cumont, Amélie
Phan, Carole
Robert, Florian
Thuillet, Raphaël
Bordenave, Jennifer
Sekine, Ayumi
Huertas, Alice
Ritvos, Olli
Savale, Laurent
Feige, Jean-Jacques
Humbert, Marc
Bailly, Sabine
Guignabert, Christophe

March 2019

Comment inThe Janus Faces of Bone Morphogenetic Protein 9 in Pulmonary Arterial Hypertension. [Circ ...

Letter by Morrell et al Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension".

Morrell, Nicholas
Upton, Paul
Li, Wei
Yu, Paul B

April 2019

We read with interest the article by Tu et al1 demonstrating that genetic loss of Bmp9 (bone morphog...

The Adult Sprague-Dawley Sugen-Hypoxia Rat Is Still "the One:" A Model of Group 1 Pulmonary Hypertension: Reply to Le Cras and Abman.

Bogaard, Harm J
Legchenko, Ekaterina
Ackermann, Maximilian
Kühnel, Mark P
Jonigk, Danny D
Chaudhary, Ketul R
Sun, Xiaoqing
Stewart, Duncan J
Hansmann, Georg

March 2020

To the editor: Kojonazarov et al. recently reported severe emphysema in the SU5416/Hypoxia (SuHx) r...

LETTERS

October 2016

Echocardiography of pulmonary vascular function in asymptomatic carriers of BMPR2 mutations To the E...

Contributions of BMPR2 Mutations and Extrinsic Factors to Cellular Phenotypes of Pulmonary Arterial Hypertension Revealed by Induced Pluripotent Stem Cell Modeling.

Kiskin, Fedir
Chang, C-Hong
Huang, Christopher JZ
Kwieder, Baraa
Cheung, Christine
Dunmore, Benjamin
Serrano, Felipe
Sinha, Sanjay
Morrell, Nicholas
Rana, Moo

July 2018

Reduced bone morphogenetic protein receptor 2 (BMPR2) signaling is central to the pathobiology of pu...

Letter by Strande Regarding Article “Protease-Activated Receptor-1 Contributes to Cardiac Remodeling and Hypertrophy” To the Editor:

October 2016

I read the article by Pawlinski et al1 with great interest. The authors showed that protease-activat...

● ● ● VASCULAR BIOLOGY Comment on Farha et al, page 3485 Bad blood, bad endothelium: ill fate?

September 2016

In this issue ofBlood, Farha and colleagues have identified amyeloproliferative process that is intr...

Letter by Hoeper and Galiè Regarding Article, "hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients with Pulmonary Arterial Hypertension of Different Causes: Phase II Results from the Pulmonary Artery Denervation-1 Study"

Hoeper, Marius M.
GALIE', NAZZARENO

January 2016

Comments on "Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Pati...

Response to Letter Regarding Article, “Protease-Activated Receptor-1 Contributes to Cardiac Remodeling and Hypertrophy”

October 2016

We recently reported that a genetic absence of protease activated receptor-1 (PAR-1) improved cardia...

Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation

Tian, Wen
Jiang, Xinguo
Sung, Yon K.
Shuffle, Eric
Wu, Ting Hsuan
Kao, Peter N.
Tu, Allen B.
Dorfmüller, Peter
Cao, Aiqin
Wang, Lingli
Peng, Gongyong
Kim, Yesl
Zhang, Patrick
Chappell, James
Pasupneti, Shravani
Dahms, Petra
Maguire, Peter
Chaib, Hassan
Zamanian, Roham
Peters-Golden, Marc
Snyder, Michael P.
Voelkel, Norbert F.
Humbert, Marc
Rabinovitch, Marlene
Nicolls, Mark R.

October 2019

Background: Bmpr2 (bone morphogenetic protein receptor 2) mutations are critical risk factors for he...

ORIGINAL ARTICLE Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats

August 2016

Abstract: Calorie restriction (CR) is one of the most effective nonpharmacological interventions pro...

Pluripotent stem cell model of pulmonary arterial hypertension

Qian, Ling

January 2017

Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.

Bogaard, Harm J
Legchenko, Ekaterina
Chaudhary, Ketul R
Sun, Xiao-Qing
Stewart, Duncan J
Hansmann, Georg

December 2019

Translational research is essential to develop strategies for the treatment of pulmonary ...

Response by Mendes-Ferreira et al to Letter Regarding Article, “Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension”

Mendes-Ferreira, Pedro
Manaud, Grégoire
Perros, Frédéric

August 2019

Comment onBmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hype...

Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension

Hautefort, Aurélie
Mendes-Ferreira, Pedro
Sabourin, Jessica
Manaud, Grégoire
Bertero, Thomas
Rucker-Martin, Catherine
Riou, Marianne
Adão, Rui
Manoury, Boris
Lambert, Mélanie
Boet, Angele
Lecerf, Florence
Domergue, Valérie
Brás-Silva, Carmen
Gómez, Ana Maria
Montani, David
Girerd, Barbara
Humbert, Marc
Antigny, Fabrice
Perros, Frédéric

February 2019

International audienceBACKGROUND: Monoallelic mutations in the gene encoding bone morphogenetic prot...

Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension

Tu, Ly
Desroches-Castan, Agnes
Mallet, Christine
Guyon, Laurent
Cumont, Amélie
Phan, Carole
Robert, Florian
Thuillet, Raphaël
Bordenave, Jennifer
Sekine, Ayumi
Huertas, Alice
Ritvos, Olli
Savale, Laurent
Feige, Jean-Jacques
Humbert, Marc
Bailly, Sabine
Guignabert, Christophe

March 2019

Comment inThe Janus Faces of Bone Morphogenetic Protein 9 in Pulmonary Arterial Hypertension. [Circ ...

Letter by Morrell et al Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension".

Morrell, Nicholas
Upton, Paul
Li, Wei
Yu, Paul B

April 2019

We read with interest the article by Tu et al1 demonstrating that genetic loss of Bmp9 (bone morphog...

The Adult Sprague-Dawley Sugen-Hypoxia Rat Is Still "the One:" A Model of Group 1 Pulmonary Hypertension: Reply to Le Cras and Abman.

Bogaard, Harm J
Legchenko, Ekaterina
Ackermann, Maximilian
Kühnel, Mark P
Jonigk, Danny D
Chaudhary, Ketul R
Sun, Xiaoqing
Stewart, Duncan J
Hansmann, Georg

March 2020

To the editor: Kojonazarov et al. recently reported severe emphysema in the SU5416/Hypoxia (SuHx) r...

LETTERS

October 2016

Echocardiography of pulmonary vascular function in asymptomatic carriers of BMPR2 mutations To the E...

Contributions of BMPR2 Mutations and Extrinsic Factors to Cellular Phenotypes of Pulmonary Arterial Hypertension Revealed by Induced Pluripotent Stem Cell Modeling.

Kiskin, Fedir
Chang, C-Hong
Huang, Christopher JZ
Kwieder, Baraa
Cheung, Christine
Dunmore, Benjamin
Serrano, Felipe
Sinha, Sanjay
Morrell, Nicholas
Rana, Moo

July 2018

Reduced bone morphogenetic protein receptor 2 (BMPR2) signaling is central to the pathobiology of pu...

Letter by Strande Regarding Article “Protease-Activated Receptor-1 Contributes to Cardiac Remodeling and Hypertrophy” To the Editor:

October 2016

I read the article by Pawlinski et al1 with great interest. The authors showed that protease-activat...

● ● ● VASCULAR BIOLOGY Comment on Farha et al, page 3485 Bad blood, bad endothelium: ill fate?

September 2016

In this issue ofBlood, Farha and colleagues have identified amyeloproliferative process that is intr...

Letter by Hoeper and Galiè Regarding Article, "hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients with Pulmonary Arterial Hypertension of Different Causes: Phase II Results from the Pulmonary Artery Denervation-1 Study"

Hoeper, Marius M.
GALIE', NAZZARENO

January 2016

Comments on "Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Pati...

Response to Letter Regarding Article, “Protease-Activated Receptor-1 Contributes to Cardiac Remodeling and Hypertrophy”

October 2016

We recently reported that a genetic absence of protease activated receptor-1 (PAR-1) improved cardia...

Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation

Tian, Wen
Jiang, Xinguo
Sung, Yon K.
Shuffle, Eric
Wu, Ting Hsuan
Kao, Peter N.
Tu, Allen B.
Dorfmüller, Peter
Cao, Aiqin
Wang, Lingli
Peng, Gongyong
Kim, Yesl
Zhang, Patrick
Chappell, James
Pasupneti, Shravani
Dahms, Petra
Maguire, Peter
Chaib, Hassan
Zamanian, Roham
Peters-Golden, Marc
Snyder, Michael P.
Voelkel, Norbert F.
Humbert, Marc
Rabinovitch, Marlene
Nicolls, Mark R.

October 2019

Background: Bmpr2 (bone morphogenetic protein receptor 2) mutations are critical risk factors for he...

ORIGINAL ARTICLE Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats

August 2016

Abstract: Calorie restriction (CR) is one of the most effective nonpharmacological interventions pro...

Pluripotent stem cell model of pulmonary arterial hypertension

Qian, Ling

January 2017

Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.

Bogaard, Harm J
Legchenko, Ekaterina
Chaudhary, Ketul R
Sun, Xiao-Qing
Stewart, Duncan J
Hansmann, Georg

December 2019

Translational research is essential to develop strategies for the treatment of pulmonary ...

Response by Mendes-Ferreira et al to Letter Regarding Article, “Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension”

Abstract

Extracted data

Response by Mendes-Ferreira et al to Letter Regarding Article, “Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension”

Abstract

Extracted data

Related items

Related items